Joseph Wetteny
Known title: Chief Financial OfficerCIK: 0001285781
Associated companies
Transaction History
| ZTS | ▲ Buy | Option Exercise | 2,050 | — | 2/19/2026 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 703 | $89K | 2/19/2026 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 1,409 | — | 2/8/2026 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 483 | $62K | 2/8/2026 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 1,388 | — | 2/6/2026 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 515 | $66K | 2/6/2026 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 1,389 | — | 2/8/2025 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 476 | $82K | 2/8/2025 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 2,936 | — | 2/8/2025 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 1,034 | $177K | 2/8/2025 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 497 | $87K | 2/6/2025 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 1,368 | — | 2/6/2025 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 20,333 | — | 6/30/2024 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 10,015 | $1.7M | 6/30/2024 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 7,693 | — | 6/30/2024 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 3,613 | $626K | 6/30/2024 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 1,374 | — | 2/8/2024 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 491 | $96K | 2/8/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Goldman Sachs initiates Zoetis coverage with Neutral rating
Goldman Sachs began covering Zoetis with a Neutral rating and a $74 price target. This follows recent guidance cuts that the market initially shrugged off, alongside a new board appointment. The stock currently trades near a key support level, with an RSI of 71.0 indicating strong recent momentum.
Goldman Sachs initiates Zoetis coverage with Neutral rating. Goldman Sachs began covering Zoetis with a Neutral rating and a $74 price target. This follows recent guidance cuts that the market initially shrugged off, alongside a new board appointment. The stock currently trades near a key support level, with an RSI of 71.0 indicating strong recent momentum.